A recombinant human parainfluenza virus type 3 (PIV3) in which the nucleocapsid N protein has been replaced by that of bovine PIV3 is attenuated in primates.
about
Bovine parainfluenza virus type 3 (BPIV3) fusion and hemagglutinin-neuraminidase glycoproteins make an important contribution to the restricted replication of BPIV3 in primates.Recombinant bovine/human parainfluenza virus type 3 (B/HPIV3) expressing the respiratory syncytial virus (RSV) G and F proteins can be used to achieve simultaneous mucosal immunization against RSV and HPIV3.A chimeric human-bovine parainfluenza virus type 3 expressing measles virus hemagglutinin is attenuated for replication but is still immunogenic in rhesus monkeys.Rescue of a chimeric rinderpest virus with the nucleocapsid protein derived from peste-des-petits-ruminants virus: use as a marker vaccineChimeric recombinant human metapneumoviruses with the nucleoprotein or phosphoprotein open reading frame replaced by that of avian metapneumovirus exhibit improved growth in vitro and attenuation in vivoMucosal immunization of rhesus monkeys against respiratory syncytial virus subgroups A and B and human parainfluenza virus type 3 by using a live cDNA-derived vaccine based on a host range-attenuated bovine parainfluenza virus type 3 vector backboneDeterminants of the host range restriction of replication of bovine parainfluenza virus type 3 in rhesus monkeys are polygenic.The hemagglutinin of canine distemper virus determines tropism and cytopathogenicity.Live-attenuated virus vaccines for respiratory syncytial and parainfluenza viruses: applications of reverse genetics.The role of reverse genetics in the development of vaccines against respiratory viruses.Evaluation of two chimeric bovine-human parainfluenza virus type 3 vaccines in infants and young childrenThe large polymerase protein is associated with the virulence of Newcastle disease virus.RNA-based viral vectors.Expression of the surface glycoproteins of human parainfluenza virus type 3 by bovine parainfluenza virus type 3, a novel attenuated virus vaccine vectorZoonotic Potential of Emerging Paramyxoviruses: Knowns and Unknowns.Identification of a natural human serotype 3 parainfluenza virus.Vaccines for the Paramyxoviruses and Pneumoviruses: Successes, Candidates, and Hurdles.
P2860
Q33604189-65888BD1-4A88-40E9-8A6E-274198294A19Q33840469-5A00DA8C-A021-4DE1-9E1A-4DAD094DA3ECQ33848343-E465F6B0-852A-493A-8D3B-3F8B5BE72F12Q33913038-09FD085A-0D6C-471E-9AEC-4E430A227F05Q34228628-20B5C434-C239-4A70-A236-D8A3B0945157Q34328895-AE49917D-DFD6-41B8-96A1-462601D3DBAFQ34465213-31FC30FF-ABFD-43D7-A739-F2AFCA700371Q34515872-D4CDB20E-5FEE-4046-956E-5FA48BAD1A79Q34717853-23B795FC-8FDE-462F-AF7A-0CDA8AD3A2DCQ36099468-7B764739-613F-4652-AB4F-5A1929D83C65Q36433111-3B33EF24-64CB-4669-8668-B4B9B6AE37A2Q36845605-A4954F92-C744-49D1-82E6-BE552DB48166Q38266413-079A5B46-DA5E-40AB-8E99-479EDE5A4517Q39593656-003FE2B7-215F-498D-8690-15C87CAF5798Q40231964-495CA8E6-0619-49C4-888F-81CFA6D59BEFQ41907672-9100E71F-F393-4285-9F90-859B227B0D0BQ47555408-A017C36F-F5A8-441B-BB6E-28AB98F7CBFA
P2860
A recombinant human parainfluenza virus type 3 (PIV3) in which the nucleocapsid N protein has been replaced by that of bovine PIV3 is attenuated in primates.
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
A recombinant human parainflue ...... IV3 is attenuated in primates.
@ast
A recombinant human parainflue ...... IV3 is attenuated in primates.
@en
type
label
A recombinant human parainflue ...... IV3 is attenuated in primates.
@ast
A recombinant human parainflue ...... IV3 is attenuated in primates.
@en
prefLabel
A recombinant human parainflue ...... IV3 is attenuated in primates.
@ast
A recombinant human parainflue ...... IV3 is attenuated in primates.
@en
P2093
P2860
P1433
P1476
A recombinant human parainflue ...... IV3 is attenuated in primates.
@en
P2093
A P Durbin
B R Murphy
J E Bailly
J M McAuliffe
P L Collins
W R Elkins
P2860
P304
P356
10.1128/JVI.74.7.3188-3195.2000
P577
2000-04-01T00:00:00Z